3.8 Article

Health trajectories before initiation of non-invasive ventilation for chronic obstructive pulmonary disease: a French nationwide database analysis

Journal

LANCET REGIONAL HEALTH-EUROPE
Volume 34, Issue -, Pages -

Publisher

ELSEVIER
DOI: 10.1016/j.lanepe.2023.100717

Keywords

Chronic obstructive pulmonary disease; Non-invasive ventilation; Health trajectories; Comorbidities; Health database

Ask authors/readers for more resources

This study investigated the health trajectories of individuals with COPD before initiating at-home NIV and compared mortality outcomes between different pre-NIV health trajectory groups. The findings revealed significant heterogeneity in clinical initiation of NIV, indicating the lack of strong evidence and guideline recommendations. Knowledge about these different clusters should be used to promote more consistent and personalized use of domiciliary NIV in COPD.
Background Chronic obstructive pulmonary disease (COPD) is the most common indication for long-term domiciliary non-invasive ventilation (NIV) but there is uncertainty in data supporting current guidelines. This study described health trajectories before initiation of at-home NIV in people with COPD, and compared mortality outcomes between groups with different pre-NIV health trajectories. Methods Data were from the French national health insurance reimbursement system database for individuals with COPD aged >= 40 years and >= 1 reimbursement for NIV between 1 January 2015 and 31 December 2019. Common health trajectories were determined using time sequence analysis through K-clustering (TAK analysis). Findings Data from 54,545 individuals were analysed; the population was elderly (median age 70 years) with multiple comorbidities. Four clusters were generated. Cluster 1 (n = 35,975/54,545; 66%) had NIV initiated in ambulatory settings or after the first acute event/exacerbation. Cluster 2 (6653/54,545; 12%) started NIV after >= 2 severe exac-erbations in the previous 6 months. Cluster 3 (11,375/54,545; 21%) started NIV after frequent severe COPD-related exacerbations in the previous year. Cluster 4 (652/54,545; 1%) started NIV after many long-lasting severe exacerbations. The four clusters differed in age, sex, comorbidities, pre-NIV investigations, and prescriber/location of NIV initiation. Mortality differed significantly between clusters: highest in Cluster 4 and lowest in Cluster 1. Interpretation The significant heterogeneity in clinical initiation of NIV probably reflects the current lack of strong evidence and guideline recommendations. Knowledge about the characteristics and outcomes in different clusters should be used to address inequities and facilitate more consistent and personalised use domiciliary NIV in COPD. Funding JLP and SB are supported by the French National Research Agency in the framework of the Investissements d'avenir program (ANR-15-IDEX-02) and the e-health and integrated care and trajectories medicine and MIAI artificial intelligence (ANR-19-P3IA-0003) Chairs of excellence from the Grenoble Alpes University Foundation. This work was supported by ResMed. Copyright (c) 2023 The Author(s). Published by Elsevier Ltd. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

3.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available